Gen Therapy

We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ...

Lecture by Luis Pereira de Almeida on the 17th of March at the Kemijski Inštitut

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ...

The CTGCT presented the project in the 3rd Teaming Club Conference in Novi Sad, Serbia.

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

The CTGCT hosted representatives from ERN ITHACA and SATB2 Europe to discuss collaborative efforts in rare disease research and treatment. The meeting focused on developing innovative therapies and strengthening connections between researchers, clinicians, and ...